top biopharmaceuticals for glp-1 medication 💊 10 Bestselling Diabetes Drugs in 2024 | Global Market Snapshot GLP-1 Therapy Weight Loss Medication

These companies currently offer five GLP-1 drugs approved for type 2 diabetes, with four also approved for various cardiovascular conditions

While it reversed the declining trend in 2021, it still lags significantly behind Keytruda, with sales nearly half of the latter's

NO.5 Biktarvy Company: Gilead 2024 worldwide sales forecast: $12.57 billion Biktarvy is a fixed-dose combination (FDC) tablet comprising bictegravir (BIC), emtricitabine (FTC), and tenofovir alafenamide (TAF) for the treatment of HIV-1 infection

Meanwhile, higher disposable income , along with better access to new pharmaceutical therapies, continues to support market expansion